SMTL ID : 7uad.1

Crystal structure of human PTPN2 with inhibitor ABBV-CLS-484

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.04 Å

Oligo State

monomer

Ligands

1 x M5R: 5-{(7R)-1-fluoro-3-hydroxy-7-[(3-methylbutyl)amino]-5,6,7,8-tetrahydronaphthalen-2-yl}-1lambda~6~,2,5-thiadiazolidine-1,1,3-trione(Non-covalent)

M5R.1: 16 residues within 4Å: Chain A: Y.50, D.52, V.53, K.124, D.184, F.185, C.218, S.219, A.220, G.221, I.222, G.223, R.224, M.258, Q.262, Q.266 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:Y.50, A:Y.50, A:V.53, A:F.185, A:A.220, A:I.222 Hydrogen bonds: A:D.52, A:K.124, A:D.184, A:D.184, A:F.185, A:S.219, A:S.219, A:A.220, A:G.221, A:I.222, A:G.223, A:R.224, A:R.224, A:R.224, A:Q.266

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baumgartner, C.K. et al., The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity. Nature (2023)

Release Date

2023-07-26

Peptides

Tyrosine-protein phosphatase non-receptor type 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 2